Asset Details
Do you wish to reserve the book?
Breaking New Ground With Endoxifen: Augmentation Strategies in OCD Management—A Case Series
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Breaking New Ground With Endoxifen: Augmentation Strategies in OCD Management—A Case Series
Do you wish to request the book?
Breaking New Ground With Endoxifen: Augmentation Strategies in OCD Management—A Case Series
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Breaking New Ground With Endoxifen: Augmentation Strategies in OCD Management—A Case Series
2025
Overview
Obsessive–compulsive (OC) disorder (OCD) is a common and potentially disabling illness with a waxing and waning course. OCD significantly disrupts the quality of life. Selective serotonin reuptake inhibitors (SSRIs) are first‐line pharmacological treatments for OCD and benefit up to half of the patients. Augmentation with low‐dose antipsychotics is an evidence‐based second‐line strategy. Psychotherapy, including cognitive behavior therapy (CBT), is used both as first and second‐line treatment. A significant portion of patients, however, do not respond to conventional treatments. We present a case series on the use of Endoxifen as an augmenting agent in patients with OCD and multiple psychiatric comorbidities who did not respond well to conventional pharmacotherapy.
Publisher
John Wiley & Sons, Inc,Wiley
Subject
